Hyperspectral imaging in diabetic foot wound care

Journal of Diabetes Science and Technology

Volumn 4, Issue 5, 2010, Pages 1099-1113

  Yudovsky, Dmitry ^a   Nouvong, Aksone ^b   Pilon, Laurent ^a  

^a Engineering IV   (United States)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

Diabetic foot ulcer; Hyperspectral imaging; Tissue oximetry; Wound care

Indexed keywords

DEOXYHEMOGLOBIN; HEMOGLOBIN; OXYHEMOGLOBIN;

DIABETIC FOOT; DIAGNOSTIC IMAGING; HUMAN; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SKIN; SPECTROSCOPY; TRANSCUTANEOUS OXYGEN MONITORING; WOUND HEALING;

BLOOD GAS MONITORING, TRANSCUTANEOUS; DIABETIC FOOT; DIAGNOSTIC IMAGING; HEMOGLOBINS; HUMANS; OXYHEMOGLOBINS; SKIN; SPECTRUM ANALYSIS; WOUND HEALING;

EID: 79952200930     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400508     Document Type: Conference Paper

References (63)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4-14.
3. Reiber GE. The epidemiology of diabetic foot problems. Diabet Med. 1996;13(Suppl 1):S6-11.
4. Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, Lavery LA, LeMaster JW, Mills JL Sr, Mueller MJ, Sheehan P, Wukich DK. Comprehensive foot examination and risk assessment. Endocr Pract. 2008;14(5):576-83.
5. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990;13(5):513-21.
6. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, Landsman AS, Lavery LA, Moore JC, Schuberth JM, Wukich DK, Andersen C, Vanore JV. Diabetic foot disorders: a clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45(5 Suppl):S1-66.
7. Shearer A, Scuffham P, Gordois A, Oglesby A. Predicted costs and outcomes from reduced vibration detection in people with diabetes in the U.S. Diabetes Care. 2003;26(8):2305-10.
8. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26(6):1790-5.
9. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998;158(2):157-62.
10. Boulton AJM. The diabetic foot. Medicine. 2006;34(3):87-90.
11. Delbridge L, Ctercteko G, Fowler C, Reeve TS, Le Quesne LP. The aetiology of diabetic neuropathic ulceration of the foot. Br J Surg. 1985;72(1):1-6.
12. Palumbo PJ, Melton LJ III. Peripheral vascular disease and diabetes. Diabetes in America. 1995;2:401-8.
13. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. Diabetes Metab Res Rev. 2000;16(Suppl 1):S84-92.
14. Jacques SL, Ramella-Roman JC, Lee K. Imaging skin pathology with polarized light. J Biomed Opt. 2002;7(3):329-40.
15. Zuzak KJ, Schaeberle MD, Lewis EN, Levin IW. Visible reflectance hyperspectral imaging: characterization of a noninvasive, in vivo system for determining tissue perfusion. Anal Chem. 2002;74(9):2021-8.
16. Tuchin VV. Tissue optics: light scattering methods and instruments for medical diagnosis, 2nd ed. San Diego (CA): SPIE Press; 2007.
17. Young AR. Chromophores in human skin. Phys Med Biol. 1997;42(5):789-802.
18. Anderson RR, Parrish JA. The optics of human skin. J Invest Dermatol. 1981;77(1):13-9.
19. Van Gemert MJC, Welch AJ, Star WM, Motamedi M, Cheong WF. Tissue optics for a slab geometry in the diffusion approximation. Lasers Med Sci. 1987;2(4):295-302.
20. Dwyer T, Prota G, Blizzard L, Ashbolt R, Vincensi MR. Melanin density and melanin type predict melanocytic naevi in 19-20 year olds of northern European ancestry. Melanoma Res. 2000;10(4):387-94.
21. Dwyer T, Muller HK, Blizzard L, Ashbolt R, Phillips G. The use of spectrophotometry to estimate melanin density in Caucasians. Cancer Epidemiol Biomarkers Prev. 1998;7(3):203-6.
22. Jacques SL. Origins of tissue optical properties in the UVA, visible, and NIR regions. In: Alfano RR, Fujimoto JG, editors. OSA TOPS on Advances in Optical Imaging and Photon Migration, vol. 2. Washington (DC): Optical Society of America; 1996. pp. 364-9.
23. Sarna T, Sealy RC. Photoinduced oxygen consumption in melanin systems. Action spectra and quantum yields for eumelanin and synthetic melanin. Photochem Photobiol. 1984;39(1):69-74.
24. Prahl S. Optical absorption of hemoglobin. Available from: http://omlc.ogi.edu/spectra/hemoglobin/, 2002.
25. Valencia IC, Falabella A, Kirsner RS, Eaglstein WH. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol. 2001;44(3):401-24.
26. Ruiz-Maldonado R, Orozco-Covarrubias ML. Postinflammatory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg. 1997;16(1):36-43.
27. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, Jensen J, Sabolinski M, Hardin-Young J. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol. 1998;134(3):293-300.
28. Phillips TJ, Dover JS. Leg ulcers. J Am Acad Dermatol. 1991; 25(6 Pt 1):965-87.
29. Sigel B, Ipsen J, Felix WR Jr. The epidemiology of lower extremity deep venous thrombosis in surgical patients. Ann Surg. 1974;179(3):278-90.
30. Greenman RL, Panasyuk S, Wang X, Lyons TE, Dinh T, Longoria L, Giurini JM, Freeman J, Khaodhiar L, Veves A. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet. 2005; 366(9498):1711-7.
31. Nouvong A, Hoogwerf B, Mohler E, Davis B, Tajaddini A, Medenilla E. Evaluation of diabetic foot ulcer healing with hyperspectral imaging of oxyhemoglobin and deoxyhemoglobin. Diabetes Care. 2009;32(11):2056-61.
32. Khaodhiar L, Dinh T, Schomacker KT, Panasyuk SV, Freeman JE, Lew R, Vo T, Panasyuk AA, Lima C, Giurini JM, Lyons TE, Veves A. The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes. Diabetes Care. 2007;30(4):903-10.
33. Vande Berg JS, Rudolph R. Pressure (decubitus) ulcer: variation in histopathology - a light and electron microscope study. Hum Pathol. 1995;26(2):195-200.
34. Sassaroli A, Fantini S. Comment on the modified Beer-Lambert law for scattering media. Phys Med Biol. 2004;49(14):N255-7.
35. Van Gemert MJ, Jacques SL, Sterenborg HJ, Star WM. Skin optics. IEEE Trans Biomed Eng. 1989;36(12):1146-54.
36. Wray S, Cope M, Delpy DT, Wyatt JS, Reynolds EO. Characterization of the near infrared absorption spectra of cytochrome aa3 and haemoglobin for the non-invasive monitoring of cerebral oxygenation. Biochim Biophys Acta. 1988;933(1):184-92.
37. Harris AP, Sendak MJ, Donham RT, Thomas M, Duncan D. Absorption characteristics of human fetal hemoglobin at wavelengths used in pulse oximetry. J Clin Monit. 1987;4(3):175-7.
38. Takatani S, Graham MD. Theoretical analysis of diffuse reflectance from a two-layer tissue model. IEEE Trans Biomed Eng. 1979;26(12):656-64.
39. Marquardt DW. An algorithm for least-squares estimation of nonlinear parameters. J Soc Indust Appl Math. 1963;11(2):431-41.
40. Yudovsky D, Pilon L. Rapid and accurate estimation of blood saturation, melanin content, and epidermis thickness from spectral diffuse reflectance. Appl Opt. 2010;49(10):1707-19.
41. Yudovsky D, Pilon L. Simple and accurate expressions for diffuse reflectance of semi-infinite and two-layer absorbing and scattering media. Appl Opt. 2009;48(35):6670-83.
42. Van Gemert MJ, Star WM. Relations between the Kubelka-Munk and the transport equation models for anisotropic scattering. Lasers Life Sci. 1987;1(98):287-98.
43. Yudovsky D, Pilon L. Retrieving skin properties from in vivo diffuse reflectance measurements on human skin. J Biophotonics. Forthcoming 2010.
44. Gambichler T, Matip R, Moussa G, Altmeyer P, Hoffmann K. In vivo data of epidermal thickness evaluated by optical coherence tomography: effects of age, gender, skin type, and anatomic site. J Dermatol Sci. 2006;44(3):145-52.
45. Sandby-Møller J, Poulsen T, Wulf HC. Epidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habits. Acta Derm Venereol. 2003;83(6):410-3.
46. Lee Y, Hwang K. Skin thickness of Korean adults. Surg Radiol Anat. 2002;24(3-4):183-9.
47. Kelly RI, Pearse R, Bull RH, Leveque JL, de Rigal J, Mortimer PS. The effects of aging on the cutaneous microvasculature. J Am Acad Dermatol. 1995;33(5 Pt 1):749-56.
48. Salomatina E, Jiang B, Novak J, Yaroslavsky AN. Optical properties of normal and cancerous human skin in the visible and near?infrared spectral range. J Biomed Opt. 2006;11(6):064026.
49. Bashkatov AN, Genina EA, Kochubey VI, Tuchin VV. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. J Phys D Appl Phys. 2005;38(15):2543-55.
50. Simpson CR, Kohl M, Essenpreis M, Cope M. Near-infrared optical properties of ex- vivo human skin and subcutaneous tissues measured using the Monte Carlo inversion technique. Phys Med Biol. 1998;43(9):2465-78.
51. Dwyer PJ, DiMarzio CA. Hyperspectral imaging for dermal hemoglobin spectroscopy. Proceedings of the SPIE - Subsurface Sensors and Applications. 1999;3752:72-82.
52. Gillies R, Freeman JE, Cancio LC, Brand D, Hopmeier M, Mansfield JR. Systemic effects of shock and resuscitation monitored by visible hyperspectral imaging. Diabetes Technol Ther. 2003;5(5):847-55.
53. Zonios G, Bykowski J, Kollias N. Skin melanin, hemoglobin, and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy. J Invest Dermatol. 2001;117(6):1452-7.
54. Kalani M, Brismar K, Fagrell B, Ostergren J, Jörneskog G. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care. 1999;22(1):147-51.
55. Sheffield PJ. Measuring tissue oxygen tension: a review. Undersea Hyperb Med. 1998;25(3):179-88.
56. Yudovsky D, Nouvong A, Schomacker K, Pilon L. Assessing diabetic foot ulcer development risk with hyperspectral tissue oximetry. J Biomed Opt. 2010. (To be Published).
57. Ferguson MW, Herrick SE, Spencer MJ, Shaw JE, Boulton AJ, Sloan P. The histology of diabetic foot ulcers. Diabet Med 1996;13(Suppl 1):S30-3.
58. Witkowski JA. Parish LC. Histopathology of the decubitus ulcer. J Am Acad Dermatol. 1982;6(6):1014-21.
59. Doi M, Tominaga S. Spectral estimation of human skin color using the Kubelka-Munk theory. Proceedings of the SPIE - Color Imaging VIII: Processing, Hardcopy, and Applications. 2003;5008:221-8. doi:10.1117/12.472026
60. Flewelling R. Noninvasive optical monitoring. In: Bronzion J, editor. The biomedical engineering handbook. Boca Roton (FL): IEEE Press; 1981. pp. 1-11.
61. Hamdy MK, Kunkle LE, Rheins MS, Deatherage FE. Bruised tissue III. Some factors affecting experimental bruises. J Anim Sci. 1957;16(2):496-501.
62. Stephenson T. Ageing of bruising in children. J R Soc Med. 1997;90(6):312-4.
63. Ryan TJ, Thoolen M, Yang YH. The effect of mechanical forces (vibration or external compression) on the dermal water content of the upper dermis and epidermis, assessed by high frequency ultrasound. J Tissue Viability. 2001;11(3):97-101. Kidney Diseases